COMMUNIQUÉS West-GlobeNewswire

Spark Therapeutics Reports 2017 Financial Results and Recent Business Progress

20/02/2018 - 13:30

PHILADELPHIA, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ: ONCE ), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, announced today corporate and [...]

NCCN Guidelines Broadly Endorse Biomarker Testing in Prostate Cancer

20/02/2018 - 13:05

SALT LAKE CITY, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN ) today announced that the National Comprehensive Cancer Network (NCCN) has updated its medical guidelines for prostate cancer [...]

Horizon Discovery Group plc: Capital Markets Day Date Change to 5 March 2018

20/02/2018 - 13:02

Horizon Discovery Group plc Capital Markets Day Date Change to 5 March 2018 Cambridge, UK, 20 February 2018: Horizon Discovery Group plc (LSE: HZD) ("Horizon" or "the Group"), a global leader in gene editing and gene [...]

Horizon Discovery Announces Leadership Changes

20/02/2018 - 13:01

Horizon Discovery Announces Leadership Changes Cambridge, UK, 20 February 2018 : Horizon Discovery Group plc (LSE: HZD) ("Horizon", "the Company", or "the Group"), a global leader in gene editing and gene modulation [...]

Obalon’s Audit Committee Investigation of Whistleblower Allegation Finds Complaint Meritless

20/02/2018 - 13:01

SAN DIEGO, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ) today announced the Audit Committee has completed its investigation into a purported whistleblower complaint and concluded that the [...]

Voyager Therapeutics and AbbVie Announce Global Strategic Collaboration to Develop Potential New Treatments for Alzheimer’s Disease and Other Tau-Related Neurodegenerative Diseases

20/02/2018 - 13:00

Collaboration to include development of gene therapies consisting of vectors to deliver monoclonal antibodies to the brain directed against tau Voyager to receive $69 million upfront payment and potentially up to $155 [...]

Blood donors urgently needed to meet patient needs leading up to spring break

20/02/2018 - 13:00

OTTAWA, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Canadian Blood Services has issued an urgent call for Canadians to give blood. More than 35,000 donors are needed by Spring Break to ensure all patients continue to have access [...]

Discovery Point Retreat Offers Drug and Alcohol Rehabilitation in Texas

20/02/2018 - 13:00

WAXAHACHIE, Texas, Feb. 20, 2018 (GLOBE NEWSWIRE) -- In an ongoing effort to help combat the substance abuse epidemic affecting the United States, Niznik Behavioral Health introduces Discovery Point Retreat, a drug and [...]

Melinta Therapeutics’ Commercial Partner Eurofarma Laboratórios Submits Marketing Authorization Application for Delafloxacin in Argentina

20/02/2018 - 13:00

NEW HAVEN, Conn., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections, today [...]

Wave Life Sciences and Takeda Form Global Strategic Collaboration to Advance Therapies for Central Nervous System Disorders

20/02/2018 - 13:00

Wave to receive at least $230 million, including $110 million in upfront cash, $60 million in equity investment and at least $60 million in research support Takeda to receive option to co-develop and co-commercialize [...]

Urgent besoin de donneurs d’ici la semaine de relâche

20/02/2018 - 13:00

OTTAWA, 20 févr. 2018 (GLOBE NEWSWIRE) -- La Société canadienne du sang lance un appel urgent au don de sang. L’organisation a besoin de 35 000 donneurs d’ici le congé du printemps pour s’assurer que tous les patients [...]

AxoGen, Inc. to Present at Canaccord Genuity Musculoskeletal Conference

20/02/2018 - 13:00

ALACHUA, Fla., Feb. 20, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN ), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced that Peter J. Mariani, [...]

Amunix announces XTEN® and ProTIA technology licensing agreement with Celgene

20/02/2018 - 13:00

MOUNTAIN VIEW, Calif., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Amunix Operating Inc. (Amunix), a biopharmaceutical company focused on the discovery and development of novel immuno-oncology therapeutics, is pleased to announce [...]

Recro Pharma Announces Publication of Supportive Phase II IV Meloxicam Bunionectomy Data in the Journal of Pain Research

20/02/2018 - 13:00

MALVERN, Pa., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq: REPH ), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care settings, today [...]

Zomedica to Participate in the Bank of America Merrill Lynch Animal Health Summit

20/02/2018 - 12:55

ANN ARBOR, Mich., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V: ZOM ) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company, today announced its [...]

Capital Senior Living Corporation Announces That Jeremy D. Falke Has Joined as Senior Vice President of Human Resources

20/02/2018 - 12:45

DALLAS, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (the “Company”) (NYSE: CSU ), one of the nation’s largest operators of senior living communities, today announced that Jeremy D. Falke has [...]

Two Additional Collaborative Human Studies on NIAGEN® with the University of Cambridge and the University of Washington Now Registered on Clinical-trials.gov.

20/02/2018 - 12:30

IRVINE, Calif., Feb. 20, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corporation (NASDAQ: CDXC ), an integrated, science-based, nutraceutical company devoted to improving the way people age, announced today that two new [...]

Dynavax Secures $175 Million in Non-Dilutive Debt Financing

20/02/2018 - 12:30

Proceeds to be Used to Commercialize HEPLISAV-B™ [Hepatitis B Vaccine (Recombinant), Adjuvanted] in United States and Advance Company’s Immuno-Oncology Product Candidates Company Deploying HEPLISAV-B Field Sales Team [...]

Transactions in relation to share buyback program

20/02/2018 - 12:23

Acting under its share buyback authorization, the GN Store Nord board of directors initiated a share buyback program on May 4, 2017 in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]